VLDL-triglyceride Kinetics in Type 2 Diabetes
Launched by UNIVERSITY OF AARHUS · Dec 22, 2009
Trial Information
Current as of June 16, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- Exclusion Criteria:
- • Known disease except type 2 diabetes (type 2 diabetic subjects)
- • Smoking
- • Alcohol abuse
- • Prescription medication expect oral antidiabetics (type 2 diabetic subjects)
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, Dk, Denmark
Patients applied
Trial Officials
Søren Nielsen, DMSc
Principal Investigator
Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials